ReviewBMC surgery2026
Passage of a percutaneous endoscopic gastrostomy tube through the liver: a case report and review of the literature.
Review in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPassage of a percutaneous endoscopic gastrostomy (PEG) tube through the liver during PEG is a rare but potentially serious complication. CASE PRESENTATION: Here, we report the case of a 78-year-old male patient with dysphagia who underwent PEG in our hospital. Follow-up abdominal computed tomography (CT) revealed that the PEG tube had passed through the left lobe of the liver. This situation poses a clinical dilemma as to whether to remove the tube or allow it to remain in place. Based on existing literature, transhepatic PEG tubes can be used for long periods of time. In our case, the sinus tract was immature and there were no immediate concerns with regards to serious complications. Therefore, we decided to retain the PEG tube and observe the patient, incorporating tube care, regular disinfection, and dressing changes. The patient has been using his PEG tube for over five years with no severe complications. To the best of our knowledge, this is the longest PEG tube has been allowed to remain in place.
conclusionsThe transhepatic insertion of a PEG tube is an extremely rare complication of PEG. Our experience indicates that a PEG tube can be retained and used for a long period of time in the absence of serious complications related to a transhepatic PEG tube. Caregivers should pay particular attention to the disinfection and daily management of PEG tubes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.